Skip to main content
Top
Published in: European Radiology 4/2018

Open Access 01-04-2018 | Gastrointestinal

The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal

Authors: Davide Prezzi, Ramin Mandegaran, Sofia Gourtsoyianni, Katarzyna Owczarczyk, Andrew Gaya, Robert Glynne-Jones, Vicky Goh

Published in: European Radiology | Issue 4/2018

Login to get access

Abstract

Objectives

To compare maximum tumour diameter (MTD) and gross tumour volume (GTV) measurements between T2-weighted (T2-w) and diffusion-weighted (DWI) MRI in squamous cell carcinoma of the anal canal (SCCA) and assess sequence impact on tumour (T) staging. Second, to evaluate interobserver agreement and reader delineation confidence.

Methods

The staging MRI scans of 45 SCCA patients (25 females) were assessed retrospectively by two independent radiologists (0 and 5 years’ experience of anal cancer MRI). MTD and GTV were delineated on both T2-w and high-b-value DWI images and compared between sequences; T staging was derived from MTD. Interobserver agreement was assessed and delineation confidence scored (1 to 5) by each observer.

Results

GTV and MTD were significantly and systematically lower on DWI versus T2-w sequences by 14.80%/9.98% (MTD) and 29.70%/12.25% (GTV) for each reader, respectively, causing T staging discordances in approximately a quarter of cases. Bland-Altman limits of agreement were narrower and intraclass correlation coefficients higher for DWI. Delineation confidence was greater on DWI: 40/42 cases were scored confidently (4 or 5) by each reader, respectively, versus 31/36 cases based on T2-w images.

Conclusions

Sequence selection affects SCCA measurements and T stage. DWI yields higher interobserver agreement and greater tumour delineation confidence.

Key Points

MTD and GTV measurements are significantly lower on DWI than on T 2 -w MRI.
Such differences cause T staging discordances in up to a quarter of cases.
DWI results in higher agreement between inexperienced and experienced observers.
DWI offers greater tumour delineation confidence to inexperienced readers.
Literature
3.
go back to reference Glynne-Jones R, Nilsson PJ, Aschele C et al (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol 111:330–339CrossRefPubMed Glynne-Jones R, Nilsson PJ, Aschele C et al (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol 111:330–339CrossRefPubMed
4.
go back to reference van der Heide UA, Houweling AC, Groenendaal G, Beets-Tan RG, Lambin P (2012) Functional MRI for radiotherapy dose painting. Magn Reson Imaging 30:1216–1223CrossRefPubMedPubMedCentral van der Heide UA, Houweling AC, Groenendaal G, Beets-Tan RG, Lambin P (2012) Functional MRI for radiotherapy dose painting. Magn Reson Imaging 30:1216–1223CrossRefPubMedPubMedCentral
5.
go back to reference Roach SC, Hulse PA, Moulding FJ, Wilson R, Carrington BM (2005) Magnetic resonance imaging of anal cancer. Clin Radiol 60:1111–1119CrossRefPubMed Roach SC, Hulse PA, Moulding FJ, Wilson R, Carrington BM (2005) Magnetic resonance imaging of anal cancer. Clin Radiol 60:1111–1119CrossRefPubMed
6.
go back to reference Koh DM, Dzik-Jurasz A, O'Neill B, Tait D, Husband JE, Brown G (2008) Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. Br J Radiol 81:91–98CrossRefPubMed Koh DM, Dzik-Jurasz A, O'Neill B, Tait D, Husband JE, Brown G (2008) Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. Br J Radiol 81:91–98CrossRefPubMed
7.
go back to reference Goh V, Gollub FK, Liaw J et al (2010) Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome? Int J Radiat Oncol Biol Phys 78:715–721CrossRefPubMed Goh V, Gollub FK, Liaw J et al (2010) Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome? Int J Radiat Oncol Biol Phys 78:715–721CrossRefPubMed
8.
go back to reference Parikh J, Shaw A, Grant LA et al (2011) Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up. Eur Radiol 21:776–785CrossRefPubMed Parikh J, Shaw A, Grant LA et al (2011) Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up. Eur Radiol 21:776–785CrossRefPubMed
9.
go back to reference Wagner M, Doblas S, Daire JL et al (2012) Diffusion-weighted MR imaging for the regional characterization of liver tumors. Radiology 264:464–472CrossRefPubMed Wagner M, Doblas S, Daire JL et al (2012) Diffusion-weighted MR imaging for the regional characterization of liver tumors. Radiology 264:464–472CrossRefPubMed
10.
go back to reference Wagner M, Ronot M, Doblas S et al (2016) Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour. Eur Radiol 26:206–215CrossRefPubMed Wagner M, Ronot M, Doblas S et al (2016) Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour. Eur Radiol 26:206–215CrossRefPubMed
11.
go back to reference Bharwani N, Miquel ME, Powles T et al (2014) Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma. Br J Cancer 110:616–624CrossRefPubMed Bharwani N, Miquel ME, Powles T et al (2014) Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma. Br J Cancer 110:616–624CrossRefPubMed
12.
go back to reference Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C (2013) The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 266:717–740CrossRefPubMed Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C (2013) The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 266:717–740CrossRefPubMed
13.
14.
go back to reference Lambregts DM, Lahaye MJ, Heijnen LA et al (2016) MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy. Eur Radiol 26:2118–2125CrossRefPubMed Lambregts DM, Lahaye MJ, Heijnen LA et al (2016) MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy. Eur Radiol 26:2118–2125CrossRefPubMed
15.
go back to reference Gourtsoyianni S, Goh V (2014) MRI of anal cancer: assessing response to definitive chemoradiotherapy. Abdom Imaging 39:2–17CrossRefPubMed Gourtsoyianni S, Goh V (2014) MRI of anal cancer: assessing response to definitive chemoradiotherapy. Abdom Imaging 39:2–17CrossRefPubMed
16.
go back to reference Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A (2010) AJCC cancer staging manual. 7th ed: Springer Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti A (2010) AJCC cancer staging manual. 7th ed: Springer
18.
go back to reference Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Methods Med Res 8:135–160CrossRefPubMed Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Methods Med Res 8:135–160CrossRefPubMed
19.
go back to reference Curvo-Semedo L, Lambregts DM, Maas M et al (2011) Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 260:734–743CrossRefPubMed Curvo-Semedo L, Lambregts DM, Maas M et al (2011) Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 260:734–743CrossRefPubMed
20.
go back to reference Regini F, Gourtsoyianni S, Cardoso De Melo R et al (2014) Rectal tumour volume (GTV) delineation using T2-weighted and diffusion-weighted MRI: Implications for radiotherapy planning. Eur J Radiol 83:768–772CrossRefPubMed Regini F, Gourtsoyianni S, Cardoso De Melo R et al (2014) Rectal tumour volume (GTV) delineation using T2-weighted and diffusion-weighted MRI: Implications for radiotherapy planning. Eur J Radiol 83:768–772CrossRefPubMed
21.
go back to reference Burbach JP, Kleijnen JP, Reerink O et al (2016) Inter-observer agreement of MRI-based tumor delineation for preoperative radiotherapy boost in locally advanced rectal cancer. Radiother Oncol 118:399–407CrossRefPubMed Burbach JP, Kleijnen JP, Reerink O et al (2016) Inter-observer agreement of MRI-based tumor delineation for preoperative radiotherapy boost in locally advanced rectal cancer. Radiother Oncol 118:399–407CrossRefPubMed
22.
go back to reference Lin M, Yu X, Chen Y, Ouyang H, Wu B, Zheng D, Zhou C (2017) Contribution of mono-exponential, bi-exponential and stretched exponential model-based diffusion-weighted MR imaging in the diagnosis and differentiation of uterine cervical carcinoma. Eur Radiol 27:2400–2410CrossRefPubMed Lin M, Yu X, Chen Y, Ouyang H, Wu B, Zheng D, Zhou C (2017) Contribution of mono-exponential, bi-exponential and stretched exponential model-based diffusion-weighted MR imaging in the diagnosis and differentiation of uterine cervical carcinoma. Eur Radiol 27:2400–2410CrossRefPubMed
24.
go back to reference (2010) The international commission on radiation units and measurements. J ICRU 10(2):5–6 (2010) The international commission on radiation units and measurements. J ICRU 10(2):5–6
25.
go back to reference Kachnic LA, Winter K, Myerson RJ et al (2013) RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 86:27–33CrossRefPubMed Kachnic LA, Winter K, Myerson RJ et al (2013) RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 86:27–33CrossRefPubMed
26.
go back to reference deSouza NM, Orton M, Downey K et al (2016) Distortion correction of echo-planar diffusion-weighted images of uterine cervix. J Magn Reson Imaging 43:1218–1223CrossRefPubMed deSouza NM, Orton M, Downey K et al (2016) Distortion correction of echo-planar diffusion-weighted images of uterine cervix. J Magn Reson Imaging 43:1218–1223CrossRefPubMed
27.
go back to reference De Foer B, Vercruysse JP, Pilet B et al (2006) Single-shot, turbo spin-echo, diffusion-weighted imaging versus spin-echo-planar, diffusion-weighted imaging in the detection of acquired middle ear cholesteatoma. AJNR Am J Neuroradiol 27:1480–1482PubMed De Foer B, Vercruysse JP, Pilet B et al (2006) Single-shot, turbo spin-echo, diffusion-weighted imaging versus spin-echo-planar, diffusion-weighted imaging in the detection of acquired middle ear cholesteatoma. AJNR Am J Neuroradiol 27:1480–1482PubMed
28.
go back to reference Geltzeiler CB, Nabavizadeh N, Kim J et al (2014) Chemoradiotherapy with a radiation boost for anal cancer decreases the risk for salvage abdominoperineal resection: analysis from the national cancer data base. Ann Surg Oncol 21:3616–3620CrossRefPubMed Geltzeiler CB, Nabavizadeh N, Kim J et al (2014) Chemoradiotherapy with a radiation boost for anal cancer decreases the risk for salvage abdominoperineal resection: analysis from the national cancer data base. Ann Surg Oncol 21:3616–3620CrossRefPubMed
29.
go back to reference Deenen MJ, Dewit L, Boot H, Beijnen JH, Schellens JH, Cats A (2013) Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study. Int J Radiat Oncol Biol Phys 85:e201–e207CrossRefPubMed Deenen MJ, Dewit L, Boot H, Beijnen JH, Schellens JH, Cats A (2013) Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study. Int J Radiat Oncol Biol Phys 85:e201–e207CrossRefPubMed
30.
go back to reference Fleckenstein J, Jelden M, Kremp S et al (2016) The impact of diffusion-weighted MRI on the definition of gross tumor volume in radiotherapy of non-small-cell lung cancer. PLoS One 11:e0162816CrossRefPubMedPubMedCentral Fleckenstein J, Jelden M, Kremp S et al (2016) The impact of diffusion-weighted MRI on the definition of gross tumor volume in radiotherapy of non-small-cell lung cancer. PLoS One 11:e0162816CrossRefPubMedPubMedCentral
Metadata
Title
The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal
Authors
Davide Prezzi
Ramin Mandegaran
Sofia Gourtsoyianni
Katarzyna Owczarczyk
Andrew Gaya
Robert Glynne-Jones
Vicky Goh
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 4/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-5133-0

Other articles of this Issue 4/2018

European Radiology 4/2018 Go to the issue